6-Quinoxalinamine (CAS No: 6298-37-9) is a key pharmaceutical intermediate used in the synthesis of APIs Brimonidine tartrate. This compound serves as an essential raw material in API development and synthesis. Explore detailed chemical properties, molecular data, structure information, and verified global suppliers, manufacturers, and distributors of this API intermediate on apicule.
Alternate Names: Quinoxalin, 6-amino-, Brimonidine EP Impurity C
CAS No: 6298-37-9
PubChem CID: 237859
Mol Formula: C8H7N3
Mol Weight: 145.16 g/mol
Used in API: Brimonidine tartrate
IUPAC Name: quinoxalin-6-amine
API Intermediate Description: 6-Quinoxalinamine (specifically 5-bromo-6-quinoxalinamine) is a key intermediate in the synthesis of Brimonidine tartrate, a glaucoma medication. It acts as the core quinoxaline structure that is brominated and coupled with an imidazoline moiety (such as N-acetyl ethylene urea or imidazoline sulfonic acid) to form the final compound, with high-yield, safe, and efficient processes often involving bromination using dibromohydantoin.
